Literature DB >> 2333945

Kinetic analysis of the downregulation of epidermal growth factor receptors in rats in vivo.

S Yanai1, Y Sugiyama, T Iga, T Fuwa, M Hanano.   

Abstract

We previously clarified the specific binding sites for epidermal growth factor (EGF) in several organs in rats based on in vivo kinetic analysis (D. C. Kim, Y. Sugiyama, H. Sato, T. Fuwa, T. Iga, and M. Hanano. J. Pharm. Sci. 77: 200-207, 1988). In the present study, we have determined the extent of the receptor downregulation and the recovery rate of the available receptors for EGF in several organs in vivo. At the specified times (30 min-24 h) after intravenous administration of excess unlabeled EGF (300 micrograms/kg), the early-phase (less than 3 min) uptake clearances (k1) of the tracer amount of 125I-EGF, which are proportional to the cell-surface available receptor densities, were determined in the liver, kidney, duodenum, jejunum, ileum, stomach, and spleen. As the result, the k1 value in each organ at 30 min after intravenous administration of unlabeled EGF was lowered close to the receptor-independent clearance value, indicating that the cell-surface receptors were almost completely downregulated, and thereafter, the k1 value showed gradual recovery to the control level. Furthermore, the recovery half-lives showed interorgan differences, namely the half-life (20 min) in the liver was much shorter than those (2-4.5 h) in other organs. These results were considered to reflect the processes of the recycling of internalized EGF receptors to the cell-surface or recruitment of new receptors. It was concluded that the recovery rate of the downregulated receptors in the liver, which is most responsible for the plasma clearance of EGF, is much faster than those in other organs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2333945     DOI: 10.1152/ajpcell.1990.258.4.C593

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  4 in total

1.  Pharmacokinetics and lung distribution of a humanized anti-RAGE antibody in wild-type and RAGE-/- mice.

Authors:  Yulia Vugmeyster; David DeFranco; Debra D Pittman; Xin Xu
Journal:  MAbs       Date:  2010-09-01       Impact factor: 5.857

2.  Existence of two pathways for the endocytosis of epidermal growth factor by rat liver: phenylarsine oxide-sensitive and -insensitive pathways.

Authors:  Y Kato; H Sato; M Ichikawa; H Suzuki; Y Sawada; M Hanano; T Fuwa; Y Sugiyama
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

3.  Heparin alters epidermal growth factor metabolism in cultured rat glomerular epithelial cells.

Authors:  S Adler
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

4.  Comparison of the methods for determining cell-surface and intracellular receptors for epidermal growth factor in the rat liver.

Authors:  S Yanai; Y Sugiyama; T Iga; T Fuwa; M Hanano
Journal:  Pharm Res       Date:  1991-05       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.